Clinical efficacy of herbal Padmapatradi yoga in bronchial asthma (Tamaka Swasa)

Background: The disease Kasa and Tamaka Shwasa mentioned by Acharya Charaka separately, both the disease are originating from Pranavaha Srotas and can damage Pranavaha Srotas permanently. Especially in Tamaka Shwasa Vyadhi, Kasa is very common as a prominent symptom. In fact patient gets more detoriated after onset of Kasa Vega and fills better when it gets subside. Though Tamaka Shwasa Vyadhi is Pitta Samudbhava, Kapha and Vata are always predominant factors. The Strotorodha made by Styana Kapha provocate Vayu excessively and result into Kasa Vega as symptom. According to Ayurveda the contain of Kasakartari Gutika is act as Kasa-shwashar property and hence for present study Kasakartari Gutika was selected as trial drug for treating the patient of Kasa in Tamaka Shwasa. Aim: To study the efficacy of ‘Kasakartari Gutika’ in the management of Kasa in Tamaka Shwasa w.s.r. to Bronchial Asthma. Material and Methods: Total 30 paients of Kasa in Tamaka Shwasa from OPD and IPD unit of Dr. M. N. Agashe Hospital, Satara, were selected and treated with Kasakartari Gutika 1gm B.D. for the duration of 2 month. Result: Maximum 81.81% relief was observed in Kshudhamandya and 80.64% relief was observed in Ayasenshwasa and 77.5% relief was observed in Kasa. Conclusion: The compound formulation ‘Kasakartari Gutika’ was found as an effective remedy for Kasa in Tamaka Shwasa. The parameters like Kasa, Ayasenshwasa and Kshudhamandya shows that they are highly significant result

Download Full-text

Clinical Efficacy of Ayurvedic formulations, Kanakasava and Trivrit Churna, in the Management of Bronchial Asthma: A Prospective, Open-label, Multicentric Study

Journal of Research in Ayurvedic Sciences ◽

10.5005/jras-10064-0096 ◽

2020 ◽

Vol 4 (1) ◽

pp. 1-9

Author(s):

Narayanam Srikanth ◽

Shruti Khanduri ◽

Sobaran Singh ◽

Thugutla Maheswar ◽

Rakesh Rana ◽

...

Keyword(s):

Bronchial Asthma ◽

Clinical Efficacy ◽

Open Label ◽

Multicentric Study

Download Full-text

Clinical Efficacy of Treatment of Children with Bronchial Asthma, Population in Remote Areas in Terms of Regional Respiratory Centre as Sanatorium Type: Work Results for 10 Years

Journal of New Medical Technologies ◽

10.12737/7279 ◽

2014 ◽

Vol 21 (4) ◽

pp. 102-108

Author(s):

Ермакова ◽

I. Ermakova

Keyword(s):

Bronchial Asthma ◽

Clinical Efficacy ◽

Clinical Examination ◽

Main Group ◽

Remote Areas ◽

Number Of Children ◽

Children With Asthma ◽

Respiratory Centre ◽

Severe Degree ◽

Efficacy Of Treatment

The purpose of this work is to improve the specialized medical care for children with bronchial asthma, people living in remote areas and villages. Materials and methods: The study involved 1,024 children with asthma (solid sample, 2003) which were observed in period of 2003 to 2013. There are 391 children-villagers as the main group; clinical examination was carried out by district pediatrician and 633 children as regional city residents (the comparison group); clinical examination was carried out by district pediatrician together with pulmonologist or allergist. The author used the methods of observation (solid documentary and selective, current, prospective) and the method of expert evaluations. Results: a significant discrepancy (p=0,03) in the evaluation by district pediatrician, practitioner or family doctor) of severity bronchial asthma and absence of bronchial asthma treatment in 28% of patients of the main group has been demonstrated in 2003. The discrepancy in the diagnosis of bronchial asthma of light degree and medium severe degree (p=0.03) were detected by a positively accepted method (examination of pulmonologist/allergist, clinical and instrumental examination, 2008). Clinical efficacy of treatment of children with bronchial asthma as residents in regional respiratory centre has been proven. For ten years the number of children with BA decreased by 25%, the number of bronchial asthma patients with moderate current (p=0.03) decreased and the number of patients with medium severe degree bronchial asthma (p=0.01) significantly increased. In 2013, the patients of the main group observations received adequate basic therapy bronchial asthma; number of children with asthma decreased in 2 times (p=0.03); the calls in the ambulance and the need for hospitalization decreased more than 2 times (p=0.03); the number of children with controlled bronchial asthma increased from 26 to 64% (p=0.05).

Download Full-text

Clinical efficacy of andriol in patients with bronchial asthma and acquired androgen deficiency

Russian Pulmonology ◽

10.18093/0869-0189-2011-0-6-99-102 ◽

2011 ◽

pp. 99-102

Author(s):

V. M. Provotorov ◽

M. A. Nikitin

Keyword(s):

Bronchial Asthma ◽

Clinical Efficacy ◽

Androgen Deficiency

Download Full-text

The clinical efficacy of prophylactic therapy of the bronchial asthma in children with an early and late onset of the disease

Bukovinian Medical Herald ◽

10.24061/2413-0737.xvii.1.65.2013.26 ◽

2013 ◽

Vol 17 (1 (65)) ◽

pp. 106-109

Author(s):

S. I. Sazhyn

Keyword(s):

Bronchial Asthma ◽

Clinical Efficacy ◽

Early Onset ◽

Odds Ratio ◽

Late Onset ◽

School Age Children ◽

Prophylactic Therapy ◽

School Age ◽

Asthma In Children ◽

Basic Treatment

The results of the clinical efficacy of basic treatment of school-age children with bronchial asthma have been presented. It has been found that patients with an early-onset phenotype of asthma had a higher risk of not gaining control over the symptoms of the disease (odds ratio – 6,0) and exacerbations (odds ratio – 2,7) compared with children whose disease set in after six years.

Download Full-text

Clinical efficacy of Kapha Ketu Rasa on Tamaka Swasa

Journal of Ayurveda and Integrated Medical Sciences (JAIMS) ◽

10.21760/jaims.v1i3.4411 ◽

2016 ◽

Vol 1 (3) ◽

Author(s):

Anuroopa HK ◽

Shankar Gouda ◽

Madhava Diggavi

Keyword(s):

Clinical Study ◽

Success Rate ◽

Bronchial Asthma ◽

Clinical Efficacy ◽

Eosinophil Count ◽

Clinical Effect ◽

Clinical Success ◽

Clinical Success Rate ◽

Therapeutic Effects

Context: Compound drugs are scientifically formulated aiming to get the desired therapeutic effects through synergy. Kapha Ketu Rasa is one such compound drug which is a classical herbo mineral marine Khalvi Rasayana judicially containing Shankha Bhasma, Vatsanabha, Tankana and Pippali. Treating GERD along with the treatment of bronchial asthma will enhance the clinical success rate. At this juncture, it is worth to notice the pharmacology of Kapha Ketu Rasa in the same perspective. Aims: To study the clinical effect of Kapha Ketu Rasa on Tamaka Swasa (Bronchial asthma). Materials and Methods: 30 Patients of Tamaka Swasa irrespective of age, sex, religion etc., were randomly selected and treated with 125 mg of Kapha Ketu Rasa capsules twice a day with Ardraka Swarasa before meals for 21 days, then followed for 21 more days. Results: The clinical study showed statistically highly significant improvement in both subjective and objective parameters viz. Kasa (91%), Ghurghurata (83%) and Swasakruchrata (82%) including decrease in AEC, ESR, Differential eosinophil count and PEF was also statistically significantly improved. Conclusions: Kapha Ketu Rasa is an effective Vyadhi Pratyanika herbo mineral Shamana Rasayana in the management of Tamaka Swasa.

Download Full-text

The effectiveness use of the combined inhalation glucocorticosteroids in the therapy of bronchial asthma

Journal of New Medical Technologies eJournal ◽

10.12737/5482 ◽

2014 ◽

Vol 8 (1) ◽

pp. 1-4

Author(s):

Лепухова ◽

O. Lepukhova

Keyword(s):

Positive Result ◽

Bronchial Asthma ◽

Clinical Efficacy ◽

Active Ingredient ◽

Inflammatory Activity ◽

Mixed Form ◽

Inhalation Device ◽

Acute Infections ◽

Aerosol Inhalation ◽

Pregnancy And Lactation

The effectiveness and comfort of using combined inhalation glucococrticosteroids in the patients with uncontrolled bronchial asthma of medium degree and mixed form was studied. As the reaction of application of different combined inhalation glucococrticosteroids for treating bronchial asthma of the same degree can be different, it is necessary to select not only the substance but also the form of using the preparations. So, for choosing the most effective preparation it was carried out an experiment with 40 patients aged from 18 to 65 with uncontrolled bronchial asthma of medium degree. The authors have excluded patients with: hyper sensibility to preparation components, acute infections of airways, pregnancy and lactation, presence a serious accompanying illness form. In the process of observation 2 patients dropped out of the experiment for different reasons. As a result 38 patients took part in research. The patients were divided into 2 groups. These patients received combined inhalation glucocorticosteroids in equivalent doses taking into account anti-inflammatory activity of glucocorticosteroid active ingredient and features of the inhalation device. The first group of patients used Foster aerosol inhalation in the dose of 100 mcg+ 6 mcg/1 dose: container 120 doses. The second group of patients received Foradil Kombi on form of gelatinous capsules, size 3 mg+12 mcg/ 1 dose together with powder for inhalations and included with the device for inhalation. Clinical efficacy of the treatment was assessed after 4 months of treatment and the positive result was detected in the second group.

Download Full-text